Sunshine Biopharma (SBFMW) Competitors $0.12 -0.04 (-26.70%) Closing price 02:32 PM EasternExtended Trading$0.12 0.00 (0.00%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock SBFMW vs. AIMDW, ALVOW, ARAV, ACABW, and RNAShould you buy Sunshine Biopharma stock or one of its competitors? MarketBeat compares Sunshine Biopharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sunshine Biopharma include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry. SBFMW vs. AIMDWSBFMW vs. ALVOWSBFMW vs. ARAVSBFMW vs. ACABWSBFMW vs. RNAHow does Sunshine Biopharma compare to Ainos?Sunshine Biopharma (NASDAQ:SBFMW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Is SBFMW or AIMDW more profitable? Company Net Margins Return on Equity Return on Assets Sunshine BiopharmaN/A N/A N/A Ainos N/A N/A N/A Which has higher valuation & earnings, SBFMW or AIMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$36.31MN/AN/AN/AN/AAinos$18.11KN/AN/AN/AN/A Does the media refer more to SBFMW or AIMDW? In the previous week, Sunshine Biopharma and Sunshine Biopharma both had 1 articles in the media. Sunshine Biopharma's average media sentiment score of 0.99 beat Ainos' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sunshine Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ainos 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySunshine Biopharma beats Ainos on 2 of the 2 factors compared between the two stocks.How does Sunshine Biopharma compare to Alvotech?Sunshine Biopharma (NASDAQ:SBFMW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Does the media refer more to SBFMW or ALVOW? In the previous week, Sunshine Biopharma had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Alvotech. Sunshine Biopharma's average media sentiment score of 0.99 beat Alvotech's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media. Company Overall Sentiment Sunshine Biopharma Positive Alvotech Neutral Which has better earnings & valuation, SBFMW or ALVOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$36.31MN/AN/AN/AN/AAlvotech$586.32MN/AN/AN/AN/A Is SBFMW or ALVOW more profitable? Company Net Margins Return on Equity Return on Assets Sunshine BiopharmaN/A N/A N/A Alvotech N/A N/A N/A SummarySunshine Biopharma beats Alvotech on 2 of the 3 factors compared between the two stocks.How does Sunshine Biopharma compare to Aravive?Aravive (NASDAQ:ARAV) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings. Do insiders & institutionals have more ownership in ARAV or SBFMW? 35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer ARAV or SBFMW? In the previous week, Sunshine Biopharma had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Aravive. Sunshine Biopharma's average media sentiment score of 0.99 beat Aravive's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Overall Sentiment Aravive Neutral Sunshine Biopharma Positive Is ARAV or SBFMW more profitable? Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A Sunshine Biopharma N/A N/A N/A Which has better valuation and earnings, ARAV or SBFMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAraviveN/AN/AN/A-$0.90N/ASunshine Biopharma$36.31MN/AN/AN/AN/A SummarySunshine Biopharma beats Aravive on 3 of the 5 factors compared between the two stocks.How does Sunshine Biopharma compare to Atlantic Coastal Acquisition Corp. II?Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Sunshine Biopharma (NASDAQ:SBFMW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations. Does the media prefer ACABW or SBFMW? In the previous week, Sunshine Biopharma had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Atlantic Coastal Acquisition Corp. II. Sunshine Biopharma's average media sentiment score of 0.99 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Overall Sentiment Atlantic Coastal Acquisition Corp. II Neutral Sunshine Biopharma Positive Is ACABW or SBFMW more profitable? Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. IIN/A N/A N/A Sunshine Biopharma N/A N/A N/A Which has stronger valuation and earnings, ACABW or SBFMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/ASunshine Biopharma$36.31MN/AN/AN/AN/A SummarySunshine Biopharma beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.How does Sunshine Biopharma compare to Avidity Biosciences?Avidity Biosciences (NASDAQ:RNA) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations. Do analysts rate RNA or SBFMW? Avidity Biosciences currently has a consensus price target of $69.42, indicating a potential upside of 436.07%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, research analysts clearly believe Avidity Biosciences is more favorable than Sunshine Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avidity Biosciences 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.37Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer RNA or SBFMW? In the previous week, Avidity Biosciences had 4 more articles in the media than Sunshine Biopharma. MarketBeat recorded 5 mentions for Avidity Biosciences and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 0.99 beat Avidity Biosciences' score of 0.80 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avidity Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sunshine Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is RNA or SBFMW more profitable? Sunshine Biopharma has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Sunshine Biopharma's return on equity of 0.00% beat Avidity Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Avidity Biosciences-3,650.39% -44.92% -39.57% Sunshine Biopharma N/A N/A N/A Which has better valuation & earnings, RNA or SBFMW? Sunshine Biopharma has lower revenue, but higher earnings than Avidity Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvidity Biosciences$36.68M6.04-$322.30MN/AN/ASunshine Biopharma$36.31MN/AN/AN/AN/A SummaryAvidity Biosciences beats Sunshine Biopharma on 6 of the 10 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBFMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFMW vs. The Competition ExportMetricSunshine BiopharmaDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.06B$6.25B$12.23BDividend YieldN/A2.96%2.80%5.32%P/E RatioN/A5.4120.7925.05Price / SalesN/A1,667.39531.2172.69Price / CashN/A10.1843.0954.25Price / BookN/A10.759.816.83Net IncomeN/A$20.70B$3.55B$335.69M7 Day PerformanceN/A-1.15%-2.07%-2.03%1 Month Performance-17.27%-4.17%-3.90%-1.90%1 Year Performance-41.03%22.32%29.39%27.36% Sunshine Biopharma Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMWSunshine BiopharmaN/A$0.12-26.7%N/A-7.7%$0.00$36.31MN/A3News CoverageAIMDWAinosN/A$0.07+13.2%N/A-54.3%$0.00$18.11KN/A40News CoverageALVOWAlvotechN/A$0.24+19.0%N/A-87.9%$0.00$586.32MN/A4Gap UpARAVAraviveN/A$0.04flatN/AN/A$0.00N/AN/A20High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.00flatN/AN/A$0.00N/AN/A15 Related Companies and Tools Related Companies Ainos Alternatives Alvotech Alternatives Aravive Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Avidity Biosciences Alternatives Biofrontera Alternatives Celularity Alternatives Cingulate Alternatives Comera Life Sciences Alternatives Dermata Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFMW) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
